AU4694999A - Use of thiazolidinedione derivatives for the treatment or prevention of cataracts - Google Patents
Use of thiazolidinedione derivatives for the treatment or prevention of cataractsInfo
- Publication number
- AU4694999A AU4694999A AU46949/99A AU4694999A AU4694999A AU 4694999 A AU4694999 A AU 4694999A AU 46949/99 A AU46949/99 A AU 46949/99A AU 4694999 A AU4694999 A AU 4694999A AU 4694999 A AU4694999 A AU 4694999A
- Authority
- AU
- Australia
- Prior art keywords
- cataracts
- prevention
- treatment
- thiazolidinedione derivatives
- thiazolidinedione
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000002177 Cataract Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 150000001467 thiazolidinediones Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9551598P | 1998-08-06 | 1998-08-06 | |
| US60095518 | 1998-08-06 | ||
| PCT/US1999/013810 WO2000007582A2 (en) | 1998-08-06 | 1999-06-18 | Use of thiazolidinedione derivatives for the treatment or prevention of cataracts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4694999A true AU4694999A (en) | 2000-02-28 |
Family
ID=22252362
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU46949/99A Abandoned AU4694999A (en) | 1998-08-06 | 1999-06-18 | Use of thiazolidinedione derivatives for the treatment or prevention of cataracts |
| AU55476/99A Abandoned AU5547699A (en) | 1998-08-06 | 1999-08-03 | Fungicidal fused bicyclic heterocycles |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU55476/99A Abandoned AU5547699A (en) | 1998-08-06 | 1999-08-03 | Fungicidal fused bicyclic heterocycles |
Country Status (2)
| Country | Link |
|---|---|
| AU (2) | AU4694999A (en) |
| WO (1) | WO2000008026A2 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20040041177A (en) * | 2001-09-26 | 2004-05-14 | 바이엘 파마슈티칼스 코포레이션 | 1,6-Naphthyridine Derivatives as Antidiabetics |
| US7737155B2 (en) * | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
| JP4975739B2 (en) * | 2005-05-17 | 2012-07-11 | シェーリング コーポレイション | Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia |
| EP2231152B1 (en) * | 2008-01-24 | 2014-01-01 | SignalRX Pharmaceuticals, Inc. | Thienopyranones as kinase inhibitors |
| CN102203090A (en) * | 2008-10-29 | 2011-09-28 | 巴斯夫欧洲公司 | Substituted pyridines having a herbicidal effect |
| WO2011051212A1 (en) * | 2009-10-28 | 2011-05-05 | Basf Se | Use of heteroaromatic compounds as herbicides |
| JP5765371B2 (en) * | 2013-06-14 | 2015-08-19 | 宇部興産株式会社 | Heterocyclic oligomer compound having a pentafluorosulfanyl group |
| WO2015149821A1 (en) * | 2014-04-03 | 2015-10-08 | Helmholtz-Zentrum für Infektionsforschung GmbH | Pqsr modulators |
| EP3133065A1 (en) | 2015-08-21 | 2017-02-22 | Merck Patent GmbH | Compounds for optically active devices |
| CN106810560B (en) * | 2016-12-23 | 2019-03-01 | 天津科技大学 | A kind of synthetic method of 8- azepine cumarin and its application in anti-tumor drug |
| JP2020506904A (en) * | 2017-01-27 | 2020-03-05 | シグナルアールエックス ファーマシューティカルズ，インコーポレイテッド | Thienopyranones and furanopyranones as kinases, bromodomains and checkpoint inhibitors |
| EP3363793A1 (en) | 2017-02-15 | 2018-08-22 | Merck Patent GmbH | Hydrophobic compounds for optically active devices |
| EP3363786A1 (en) | 2017-02-15 | 2018-08-22 | Merck Patent GmbH | Compounds for optically active devices |
| US12570668B2 (en) * | 2018-07-23 | 2026-03-10 | Signalrx Pharmaceuticals, Inc. | Single molecule compounds providing multi-target inhibition of BTK and other proteins and methods of use thereof |
| KR20230012616A (en) | 2020-05-20 | 2023-01-26 | 에이엠오 아일랜드 | Azacoumarin and azathiocoumarin derivatives for use in optically active devices |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4103257A (en) * | 1976-05-25 | 1978-07-25 | The United States Of America As Represented By The United States Department Of Energy | Azaquinolone dye lasers |
| DE4308014A1 (en) * | 1993-03-13 | 1994-09-15 | Hoechst Schering Agrevo Gmbh | Condensed nitrogen heterocycles, processes for their preparation and their use as pesticides and fungicides |
| JPH07126268A (en) * | 1993-10-29 | 1995-05-16 | Otsuka Pharmaceut Factory Inc | 1,8-naphthyridine derivative |
| PL187175B1 (en) * | 1995-10-13 | 2004-05-31 | Bayer Cropscience Ltd | Heterocyclic fungicides |
| US6294527B1 (en) * | 1996-12-25 | 2001-09-25 | Zenyaku Kogyo Kabushiki Kaisha | Cephem compounds |
| AU7132998A (en) * | 1997-04-24 | 1998-11-13 | Ortho-Mcneil Corporation, Inc. | Substituted pyrrolopyridines useful in the treatment of inflammatory diseases |
-
1999
- 1999-06-18 AU AU46949/99A patent/AU4694999A/en not_active Abandoned
- 1999-08-03 AU AU55476/99A patent/AU5547699A/en not_active Abandoned
- 1999-08-03 WO PCT/US1999/017707 patent/WO2000008026A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000008026A3 (en) | 2000-08-10 |
| WO2000008026A2 (en) | 2000-02-17 |
| AU5547699A (en) | 2000-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AUPP609198A0 (en) | Use of non-peptidyl compounds for the treatment of insulin related ailments | |
| AU2935200A (en) | Compounds for the treatment of obesity | |
| AU2002364300A1 (en) | Polymer derivatives for the treatment of metals | |
| AU7622000A (en) | Compounds for the treatment of viral-mediated diseases | |
| AU4694999A (en) | Use of thiazolidinedione derivatives for the treatment or prevention of cataracts | |
| ZA9811629B (en) | The use of MMP inhibitors for the treatment of ocular angiogenesis. | |
| AU2001253165A1 (en) | Use of fluorocarbons for the prevention of surgical adhesions | |
| AU5038299A (en) | Process for the biocidal treatment of surfaces | |
| AU2001256855A1 (en) | Preparation for the prevention and treatment of ocular disorders | |
| AU2002217866A1 (en) | Geldanamycin derivatives useful for the treatment of cancer | |
| AU6330999A (en) | Rhodanine derivatives for the treatment and prevention of metabolic bone disorders | |
| AU2002300593A1 (en) | Process for the preparation of thiazolidinedione derivatives | |
| AU1878201A (en) | Composition for the treatment of damaged tissue | |
| AU2021601A (en) | Composition for the treatment of dandruff | |
| AU2001264522A1 (en) | Methods and compositions for the prevention of myopia | |
| AU3814599A (en) | Use of erythropoietin for the treatment of haemochromatoses | |
| AU4228000A (en) | Methods and compositions for the treatment and prevention of lung disease | |
| AU6331099A (en) | Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders | |
| AU2002215187A1 (en) | S-adenosylmethionine and derivatives thereof for the treatment and prevention ofalzheimer's disease | |
| AU2182800A (en) | Use of inhibitors of gag synthesis for the treatment of corneal haze | |
| AU5494298A (en) | Pharmaceutical compositions for the treatment of the eye | |
| AU1022501A (en) | Use of compositions for the caring treatment of the skin | |
| AU3501100A (en) | Synergistic combination for treatment of viral-mediated diseases | |
| AU7961800A (en) | Thiazolidinedione derivatives | |
| AU4225500A (en) | Methods and compositions for the treatment and prevention of lung disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |